Headquarters
France
team size
5 - 9
founded
2014
website
http://aavlife.com
funding probability score
total disclosed funding
last round valuation estimate
disclosed funding rounds
latest round
latest funding stage
next round estimate
development stage
number of investors
number of competitors
monthly web visits
twitter followers
Offices
France
HQ address
183 Avenue de Choisy, Paris, 75013, FRA
description
AAVLife is a gene therapy company focused on developing treatments for rare diseases with great unmet medical need. Our lead indication is for the cardiomyopathy associated with Friedreich’s Ataxia. Our program is based on the successful use of a gene-therapy approach in a mouse model developed to mimic the gene defect and cardiac symptoms of Friedreich’s Ataxia. The approach made use of an adeno-associated virus (AAV) to introduce a normal gene into cardiac tissue. The therapy restored cardiac function and reversed pathological heart enlargement in mice that had already progressed to heart failure.

There is much more to this profile.
Log in or sign up for free to see the whole thing.

Get free access to these powerful tools:
- Advanced search filters
- Full startup and investor profiles
- Follow startups and investors
- Custom follow-lists
- Startup benchmarking
- Network maps
- Market stats